Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.67 |
| ▸ | CCR5 | P51681 | 2/20 | 0.67 |
| ▸ | CCR8 | P51685 | 2/20 | 0.67 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.49 |
| ▸ | COPS5 | Q92905 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | SLC40A1 | Q9NP59 | 5/20 | 0.41 |
| ▸ | NFKBIA | P25963 | 1/20 | 0.38 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | HTR2A | P28223 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.34 |
| ▸ | PDE2A | O00408 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10838838 | 0.85 | CCR1 (0.67) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL6888604 | 0.85 | CCR1 (0.67) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL29890061 | 0.85 | CCR1 (0.67) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL22326612 | 0.81 | CCR1 (0.62) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL14841997 | 0.81 | CCR1 (0.62) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL30492603 | 0.81 | CCR1 (1.00) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL686948 | 0.81 | CCR1 (1.00) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL27891657 | 0.80 | CCR1 (0.60) | CCR1CCR5CCR8PSMD14COPS5 | |
| SCHEMBL30505759 | 0.80 | CCR1 (0.39) | CCR1CCR5CCR8PDE10ACYP2A6 | |
| SCHEMBL27840289 | 0.80 | CCR1 (0.39) | CCR1CCR5CCR8PDE10ACYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110903279-B | Pyrazole compound, salt and application thereof | 潍坊中农联合化工有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-11219214-B2 | Benzosultams and analogues and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2022-01-11 | — | — | US | disclosed |
| US-20200323211-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-10-15 | — | — | US | disclosed |
| US-10736321-B2 | Benzosultams and analogues and their use as fungicides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2020-08-11 | — | — | US | disclosed |
| US-5625068-A | Substituted quinoline herbicide intermediates and process | AMERICAN CYANAMID COMPANY (US) | 1997-04-29 | — | — | US | disclosed |
| EP-0747361-A1 | Substituted quinoline herbicide intermediates and process | American Cyanamid Company (US) | 1996-12-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200323211-A1 | BENZOSULTAMS AND ANALOGUES AND THEIR USE AS FUNGICIDES | GABBR1, DPM1, CYP51A1 | CCR1 4876/4885CCR5 4873/4885CCR8 4830/4885 |
| US-10736321-B2 | Benzosultams and analogues and their use as fungicides | GABBR1, DPM1, CYP51A1 | CCR1 4876/4885CCR5 4873/4885CCR8 4830/4885 |
| US-11219214-B2 | Benzosultams and analogues and their use as fungicides | GABBR1, DPM1, CYP51A1 | CCR1 4876/4885CCR5 4873/4885CCR8 4830/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.